Ross Merkin

9PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2026
Clinical validation of an HPV whole-genome sequencing assay for MRD detection in patients with HPV+ head and neck cancer treated with surgery.

|Jul 04, 2025
Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.

Nikhil Dubey, Chia-Yun Wu, Leyre Zubiri

|May 20, 2025
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.

Michael E Bryan, Ling Aye, Dipon Das

|Apr 20, 2025
Reversible downregulation of HLA class I in adenoid cystic carcinoma.

Annie Li, Bianca L Gonda, Elizabeth M Codd

|Apr 11, 2025
Outcomes for recurrent or metastatic head and neck cancer by HPV status: a systematic review and meta-analysis.

Jong Chul Park, Geun Hee Ye, Ross Merkin

|Jan 27, 2025
Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy.

Jong Chul Park, Jong Seok Ahn, Ross Merkin

Pageof 2

Frequent Collaborators

5 joint publications

Lori Wirth

4 joint publications

Daniel L Faden

3 joint publications

Peter M Sadow

3 joint publications

Jong Chul Park